Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Recurrence"" wg kryterium: Temat


Tytuł :
HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life.
Autorzy :
Wesselmann P; Department of Surgery, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
Schwarze-Zander C; Department of Medicine I, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
Boesecke C; Department of Medicine I, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
Rockstroh J; Department of Medicine I, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
Stoffels B; Department of Surgery, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
Vilz TO; Department of Surgery, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
Glowka TR; Department of Surgery, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
Kalff JC; Department of Surgery, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany.
von Websky MW; Department of Surgery, University Hospital of Bonn, Sigmund-Freud-Str. 25, Bonn, Germany. .
Pokaż więcej
Źródło :
International journal of colorectal disease [Int J Colorectal Dis] 2020 Jun; Vol. 35 (6), pp. 1103-1110. Date of Electronic Publication: 2020 Mar 26.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local*
Quality of Life*
Anus Neoplasms/*complications
Carcinoma in Situ/*complications
Condylomata Acuminata/*complications
HIV Seropositivity/*complications
Adolescent ; Adult ; Anus Neoplasms/pathology ; Anus Neoplasms/psychology ; Anus Neoplasms/therapy ; Carcinoma in Situ/pathology ; Carcinoma in Situ/psychology ; Carcinoma in Situ/therapy ; Condylomata Acuminata/psychology ; Condylomata Acuminata/therapy ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Recurrence ; Sexual Behavior ; Stress, Psychological/etiology ; Surveys and Questionnaires ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Late relapses in diffuse large B-cell lymphoma: where to move next?
Autorzy :
Nijland M; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2020 May; Vol. 61 (5), pp. 1005-1006. Date of Electronic Publication: 2020 Feb 04.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Lymphoma, Large B-Cell, Diffuse*
Neoplasm Recurrence, Local*
Humans ; Recurrence ; Rituximab ; Vincristine
Czasopismo naukowe
Tytuł :
Breast ductal Carcinoma in situ associated with microinvasion induces immunological response and predicts ipsilateral invasive recurrence.
Autorzy :
Chen XY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Thike AA; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.
Koh VCY; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Nasir NDM; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Bay BH; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Tan PH; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore. .; Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. .; Duke-NUS Medical School, Singapore, Singapore. .; Division of Pathology, Singapore General Hospital, Singapore, Singapore. .
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 Apr; Vol. 478 (4), pp. 679-686. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*metabolism
Breast Neoplasms/*immunology
Breast Neoplasms/*pathology
Carcinoma, Intraductal, Noninfiltrating/*immunology
Carcinoma, Intraductal, Noninfiltrating/*pathology
Neoplasm Recurrence, Local/*immunology
Neoplasm Recurrence, Local/*pathology
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/metabolism ; Breast Neoplasms/therapy ; Carcinoma, Intraductal, Noninfiltrating/metabolism ; Carcinoma, Intraductal, Noninfiltrating/therapy ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/prevention & control ; Prognosis ; Proportional Hazards Models
Czasopismo naukowe
Tytuł :
Isatuximab for the treatment of relapsed/refractory multiple myeloma.
Autorzy :
Richardson PG; Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Dana-Farber Cancer Institute , Boston, MA, USA.
Beksaç M; Department of Hematology, School of Medicine, Ankara University , Ankara, Turkey.
Špička I; 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital , Prague, Czech Republic.
Mikhael J; Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute, City of Hope Cancer Center , Phoenix, AZ, USA.
Pokaż więcej
Źródło :
Expert opinion on biological therapy [Expert Opin Biol Ther] 2020 Dec; Vol. 20 (12), pp. 1395-1404.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Drug Resistance, Neoplasm/*drug effects
Multiple Myeloma/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Adult ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Lenalidomide/therapeutic use ; Multiple Myeloma/pathology ; Neoplasm Recurrence, Local/pathology ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients.
Autorzy :
Gwark S; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim J; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. .
Kwon NJ; Macrogen Inc, Seoul, Korea.
Kim KY; Macrogen Inc, Seoul, Korea.
Kim Y; Macrogen Inc, Seoul, Korea.
Lee CH; Cytogen Inc, Seoul, Korea.
Kim YH; Cytogen Inc, Seoul, Korea.
Kim MS; Cytogen Inc, Seoul, Korea.
Hong SW; Cytogen Inc, Seoul, Korea.
Choi MY; Cytogen Inc, Seoul, Korea.
Jeon BH; Cytogen Inc, Seoul, Korea.
Chang S; Department of Biomedical Sciences, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Yu J; Department of Surgery, Division of Breast and Endocrine Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
Park JY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Lee HJ; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Lee SB; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Chung IY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Ko BS; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim HJ; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Lee JW; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Son BH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Ahn JH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Jung KH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Kim SB; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Gong GY; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Ahn SH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Oct 15; Vol. 10 (1), pp. 17466. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Breast Neoplasms/*drug therapy
Neoplasm Recurrence, Local/*pathology
Neoplastic Cells, Circulating/*pathology
Triple Negative Breast Neoplasms/*drug therapy
Adult ; Aged ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/blood ; Cell Count ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Estrogen Receptor alpha/metabolism ; Female ; Follow-Up Studies ; Humans ; MCF-7 Cells ; Microscopy, Fluorescence ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local/blood ; Neoplasm, Residual/blood ; Neoplasm, Residual/drug therapy ; Prognosis ; Receptor, ErbB-2/metabolism ; Recurrence ; Treatment Outcome ; Triple Negative Breast Neoplasms/blood
Czasopismo naukowe
Tytuł :
Potential Benefits of Minimally Invasive Laparoscopy in Reducing Local Recurrence After Surgery for Low Rectal Cancer.
Autorzy :
Numata M; Department of Surgery, Yokohama City University, Yokohama, Japan; .
Tamagawa H; Department of Surgery, Yokohama City University, Yokohama, Japan.
Kazama K; Department of Surgery, Yokohama City University, Yokohama, Japan.
Atsumi Y; Department of Surgery, Yokohama City University, Yokohama, Japan.
Iguchi K; Department of Surgery, Yokohama City University, Yokohama, Japan.
Sawazaki S; Department of Surgery, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Aoyama T; Department of Surgery, Yokohama City University, Yokohama, Japan.
Sato S; Department of Surgery, Yokohama City University, Yokohama, Japan.
Sugano N; Department of Surgery, Yokohama City University, Yokohama, Japan.
Godai T; Department of Surgery, Fujisawa Shonandai Hospital, Fujisawa, Japan.
Higuchi A; Department of Surgery, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Saigusa Y; Department of Biostatistics, Yokohama City University, Yokohama, Japan.
Saeki H; Department of Surgery, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Yamada T; Department of Gastroenterological Surgery, Kanagawa Cancer Hospital, Yokohama, Japan.
Oshima T; Department of Gastroenterological Surgery, Kanagawa Cancer Hospital, Yokohama, Japan.
Shiozawa M; Department of Gastroenterological Surgery, Kanagawa Cancer Hospital, Yokohama, Japan.
Yukawa N; Department of Surgery, Yokohama City University, Yokohama, Japan.
Rino Y; Department of Surgery, Yokohama City University, Yokohama, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 May; Vol. 41 (5), pp. 2617-2623.
Typ publikacji :
Journal Article
MeSH Terms :
Laparoscopy*
Minimally Invasive Surgical Procedures*
Neoplasm Recurrence, Local/*surgery
Rectal Neoplasms/*surgery
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/pathology ; Rectal Neoplasms/epidemiology ; Rectal Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
Autorzy :
Elliot AH; Department of Molecular Medicine and Surgery, Karolinska Institutet, Division of Coloproctology, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden; .
Othman BN; Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.
Suzuki C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.
Blomqvist L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.
Martling A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Division of Coloproctology, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
Johansson H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Nilsson PJ; Department of Molecular Medicine and Surgery, Karolinska Institutet, Division of Coloproctology, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
Iversen H; Department of Molecular Medicine and Surgery, Karolinska Institutet, Division of Coloproctology, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 May; Vol. 41 (5), pp. 2459-2465.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Angiography*
Neoplasm Recurrence, Local/*surgery
Rectal Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Chemoradiotherapy/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Rectal Neoplasms/diagnostic imaging ; Rectal Neoplasms/drug therapy ; Rectal Neoplasms/radiotherapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The optimal cut-off value of immunohistochemical parameter P53 for predicting recurrence of endometrial cancer.
Autorzy :
Jia M; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jiang P; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hu J; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Huang Z; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Deng Y; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hu Z; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło :
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2021 May; Vol. 153 (2), pp. 344-350. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji :
Journal Article
MeSH Terms :
Endometrial Neoplasms/*genetics
Neoplasm Recurrence, Local/*genetics
Tumor Suppressor Protein p53/*genetics
Adult ; Aged, 80 and over ; Biomarkers, Tumor/analysis ; Endometrial Neoplasms/mortality ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/mortality ; ROC Curve ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The risk factors of local recurrence and distant metastasis on pT1/T2N0 mid-low rectal cancer after total mesorectal excision.
Autorzy :
Lai IL; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
You JF; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
Chern YJ; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
Tsai WS; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
Chiang JM; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
Hsieh PS; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
Hung HY; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan.
Hsu YJ; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Linkou, No.5, Fu-Hsing Street, Guei-Shan, Tao-Yuan, Taiwan. .
Pokaż więcej
Źródło :
World journal of surgical oncology [World J Surg Oncol] 2021 Apr 13; Vol. 19 (1), pp. 116. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/surgery
Rectal Neoplasms*/pathology
Rectal Neoplasms*/surgery
Humans ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Have Volume-based Parameters of Positron Emission Tomography/Computed Tomography Prognostic Relevance for Patients With Potentially Platinum-responsive Recurrent Ovarian Cancer? A Single Center Italian Study.
Autorzy :
Gadducci A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy; .
Simonetti E; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
Guidoccio F; Regional Center of Nuclear Medicine, Department of Translational Research, University of Pisa, Pisa, Italy.
Manca G; Regional Center of Nuclear Medicine, Department of Translational Research, University of Pisa, Pisa, Italy.
Giorgetti A; Fondazione CNR/Regione Toscana 'Gabriele Monasterio', Pisa, Italy.
Depalo T; Regional Center of Nuclear Medicine, Department of Translational Research, University of Pisa, Pisa, Italy.
Cosio S; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
Miccoli M; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
Volterrani D; Regional Center of Nuclear Medicine, Department of Translational Research, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Apr; Vol. 41 (4), pp. 1937-1944.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Ovarian Epithelial/*diagnosis
Neoplasm Recurrence, Local/*diagnosis
Ovarian Neoplasms/*diagnosis
Positron Emission Tomography Computed Tomography/*methods
Tumor Burden/*physiology
Adult ; Aged ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/pathology ; Drug Resistance, Neoplasm/drug effects ; Female ; Fluorodeoxyglucose F18 ; Humans ; Italy ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Platinum Compounds/therapeutic use ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Treatment Outcome ; Tumor Burden/drug effects
Czasopismo naukowe
Tytuł :
Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study.
Autorzy :
Yoshikawa K; Department of Pathology and Clinical Laboratory, Kansai Medical University, Osaka, Japan.; Department of Surgery, Kansai Medical University, Osaka, Japan.
Ishida M; Department of Pathology and Clinical Laboratory, Kansai Medical University, Osaka, Japan.
Yanai H; Department of Surgery, Kansai Medical University, Osaka, Japan.
Tsuta K; Department of Pathology and Clinical Laboratory, Kansai Medical University, Osaka, Japan.
Sekimoto M; Department of Surgery, Kansai Medical University, Osaka, Japan.
Sugie T; Department of Surgery, Kansai Medical University, Osaka, Japan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 17; Vol. 15 (11), pp. e0242563. Date of Electronic Publication: 2020 Nov 17 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local/*genetics
Perilipin-2/*genetics
Triple Negative Breast Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Female ; Gene Expression/genetics ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Middle Aged ; Perilipin-2/metabolism ; Prognosis ; Recurrence ; Triple Negative Breast Neoplasms/immunology ; Triple Negative Breast Neoplasms/metabolism
Czasopismo naukowe
Tytuł :
Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies.
Autorzy :
Ekeke CN; Department of Cardiothoracic Surgery, The University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, 200 Lothrop Street, Suite C800, Pittsburgh, PA 15213, USA.
Chan EG; Department of Cardiothoracic Surgery, The University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, 200 Lothrop Street, Suite C800, Pittsburgh, PA 15213, USA.
Fabian T; Department of Surgery, Section of Thoracic Surgery, Albany Medical Center, 43 New Scotland Avenue, MC-50, R-113, Albany, NY 12208, USA.
Villa-Sanchez M; Department of Cardiothoracic Surgery, The University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, 200 Lothrop Street, Suite C800, Pittsburgh, PA 15213, USA.
Luketich JD; Department of Cardiothoracic Surgery, The University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, 200 Lothrop Street, Suite C816, Pittsburgh, PA 15213, USA. Electronic address: .
Pokaż więcej
Źródło :
The Surgical clinics of North America [Surg Clin North Am] 2021 Jun; Vol. 101 (3), pp. 415-426.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Esophagoscopy*
Aftercare/*methods
Esophageal Neoplasms/*diagnosis
Esophageal Neoplasms/*therapy
Neoplasm Recurrence, Local/*diagnosis
Neoplasm Recurrence, Local/*therapy
Ablation Techniques/methods ; Adenocarcinoma/diagnosis ; Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Carcinoma, Squamous Cell/diagnosis ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/therapy ; Endoscopic Mucosal Resection ; Esophageal Neoplasms/pathology ; Esophagectomy/methods ; Humans ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging
Czasopismo naukowe
Tytuł :
Surveillance Following Treatment of Esophageal Cancer.
Autorzy :
Bakhos CT; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University Hospital, 3401 North Broad Street C-501, Philadelphia, PA 19140, USA. Electronic address: .
Acevedo E Jr; Department of Surgery, Temple University Hospital, 3401 North Broad Street C-501, Philadelphia, PA 19140, USA.
Petrov RV; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University Hospital, 3401 North Broad Street C-501, Philadelphia, PA 19140, USA.
Abbas AE; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University Hospital, Temple University Health System, 3401 North Broad Street C-501, Philadelphia, PA 19140, USA.
Pokaż więcej
Źródło :
The Surgical clinics of North America [Surg Clin North Am] 2021 Jun; Vol. 101 (3), pp. 499-509.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Chemoradiotherapy*
Adenocarcinoma/*diagnosis
Aftercare/*methods
Carcinoma, Squamous Cell/*diagnosis
Esophageal Neoplasms/*diagnosis
Neoplasm Recurrence, Local/*diagnosis
Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/therapy ; Esophageal Neoplasms/pathology ; Esophageal Neoplasms/therapy ; Esophagectomy ; Esophagoscopy ; Humans ; Neoadjuvant Therapy ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Neoplasm Staging ; Neoplasm, Residual
Czasopismo naukowe
Tytuł :
Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.
Autorzy :
Yang SW; Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Keelung, No. 222, Mai Chin Road, Keelung, 204, Taiwan, Republic of China. .; College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China. .
Lee YS; Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China.; Department of Biotechnology, Ming Chuan University, Taoyuan, Taiwan, Republic of China.
Chang LC; College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China.; Department of Pathology, Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.
Yang CH; College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China.; Department of Pathology, Chang Gung Memorial Hospital, Keelung, Taiwan, Republic of China.
Luo CM; Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Keelung, No. 222, Mai Chin Road, Keelung, 204, Taiwan, Republic of China.; College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China.
Wu PW; Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Keelung, No. 222, Mai Chin Road, Keelung, 204, Taiwan, Republic of China.; College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China.
Pokaż więcej
Źródło :
Clinical oral investigations [Clin Oral Investig] 2021 Jun; Vol. 25 (6), pp. 4045-4058. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :
Journal Article
MeSH Terms :
Leukoplakia, Oral*/surgery
Neoplasm Recurrence, Local*
Cell Transformation, Neoplastic ; Humans ; Retrospective Studies ; Tongue ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer.
Autorzy :
Takada K; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Kashiwagi S; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan. .
Asano Y; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Goto W; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Kouhashi R; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Yabumoto A; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Ishihara S; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Morisaki T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Shibutani M; Department of Gastrointestinal Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Tanaka H; Department of Gastrointestinal Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Hirakawa K; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.; Department of Gastrointestinal Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Ohira M; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.; Department of Gastrointestinal Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Pokaż więcej
Źródło :
BMC women's health [BMC Womens Health] 2021 May 29; Vol. 21 (1), pp. 225. Date of Electronic Publication: 2021 May 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphocytes, Tumor-Infiltrating*
Neoplasm Recurrence, Local*
Chemotherapy, Adjuvant ; Hormones ; Humans ; Prognosis ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Co-evolution of tumor and immune cells during progression of multiple myeloma.
Autorzy :
Liu R; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Gao Q; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Foltz SM; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Fowles JS; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Yao L; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Wang JT; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Cao S; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Sun H; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Wendl MC; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.; Department of Genetics, Washington University in St. Louis, St. Louis, MO, USA.; Department of Mathematics, Washington University in St. Louis, St. Louis, MO, USA.
Sethuraman S; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Weerasinghe A; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Rettig MP; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Storrs EP; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Yoon CJ; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Wyczalkowski MA; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
McMichael JF; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Kohnen DR; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
King J; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Goldsmith SR; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
O'Neal J; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Fulton RS; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Fronick CC; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Ley TJ; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Jayasinghe RG; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA.
Fiala MA; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Oh ST; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; Center for Human Immunology and Immunotherapy Programs, Washington University in St. Louis, St. Louis, MO, USA.
DiPersio JF; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO, USA.
Vij R; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA. .; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO, USA. .
Ding L; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA. .; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA. .; Department of Genetics, Washington University in St. Louis, St. Louis, MO, USA. .; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 May 07; Vol. 12 (1), pp. 2559. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
B-Lymphocytes/*metabolism
Gene Expression Regulation, Neoplastic/*genetics
Multiple Myeloma/*genetics
Multiple Myeloma/*immunology
Neoplasm Recurrence, Local/*genetics
Tumor Microenvironment/*immunology
Aged ; B-Lymphocytes/cytology ; B-Lymphocytes/immunology ; Cell Lineage ; Clonal Evolution/genetics ; Cohort Studies ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic/immunology ; Haplotypes ; Humans ; Interleukin-1beta/blood ; Interleukin-6/blood ; Male ; Mass Spectrometry ; Middle Aged ; Multigene Family ; Multiple Myeloma/blood ; Multiple Myeloma/pathology ; Mutation ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/immunology ; Proto-Oncogene Proteins c-fos/blood ; Proto-Oncogene Proteins c-jun/blood ; RNA-Seq ; Signal Transduction/genetics ; Signal Transduction/immunology ; Single-Cell Analysis
Czasopismo naukowe
Tytuł :
Long event-free survival after anti-BCMA CAR-T cell treatment for relapsed and refractory multiple myeloma patients: Two case reports.
Autorzy :
Xu J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R.China.
Ming X
Wang C
Xu B
Xiao Y
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 May 07; Vol. 100 (18), pp. e25784.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
B-Cell Maturation Antigen/*antagonists & inhibitors
Immunotherapy, Adoptive/*methods
Multiple Myeloma/*therapy
Neoplasm Recurrence, Local/*therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bone Marrow/pathology ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/pathology ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/pathology ; Receptors, Chimeric Antigen/immunology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival.
Autorzy :
Orsaria P; Department of Breast Surgery, Campus Bio-Medico University, Rome, Italy; .
Grasso A; Department of Breast Surgery, Campus Bio-Medico University, Rome, Italy.
Ippolito E; Department of Radiation Oncology, Campus Bio-Medico University, Rome, Italy.
Pantano F; Department of Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Sammarra M; Department of Radiology, Campus Bio-Medico University, Rome, Italy.
Altomare C; Department of Radiology, Campus Bio-Medico University, Rome, Italy.
Cagli B; Department of Reconstructive Surgery, Campus Bio-Medico University, Rome, Italy.
Costa F; Department of Anaesthesia, Intensive Care and Pain Management, Campus Bio-Medico University, Rome, Italy.
Perrone G; Department of Anatomical Pathology, Campus Bio-Medico University, Rome, Italy.
Soponaru G; Department of Breast Surgery, Campus Bio-Medico University, Rome, Italy.
Caggiati L; Department of Breast Surgery, Campus Bio-Medico University, Rome, Italy.
Vanni G; Department of Breast Surgery, Tor Vergata University Hospital, Rome, Italy.
Buonomo OC; Department of Breast Surgery, Tor Vergata University Hospital, Rome, Italy.
Altomare V; Department of Breast Surgery, Campus Bio-Medico University, Rome, Italy.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 May; Vol. 41 (5), pp. 2697-2709.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Receptor, ErbB-2/*genetics
Triple Negative Breast Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/epidemiology ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy/adverse effects ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Treatment Outcome ; Triple Negative Breast Neoplasms/epidemiology ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Adaptive Radiation Therapy for Intact Thymoma: An Illustrative Report.
Autorzy :
Chevli N; Department of Radiation Oncology, University of Texas Medical Branch at Galveston, Galveston, TX, U.S.A.
Bland RE; Radiation Oncology, Northeast Louisiana Cancer Institute, Monroe, LA, U.S.A.
Farach AM; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A.
Pino R; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A.
Mathews T; Department of Radiation Oncology, Inova-Alexandria Hospital, Alexandria, VA, U.S.A.
Okoye EI; Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, TX, U.S.A.
Blackmon S; Department of Thoracic Surgery, Mayo Clinic, Rochester, MN, U.S.A.
Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A.
Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, U.S.A.; .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 May; Vol. 41 (5), pp. 2467-2471.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Neoplasm Recurrence, Local/*drug therapy
Neoplasm Recurrence, Local/*radiotherapy
Thymoma/*drug therapy
Thymoma/*radiotherapy
Adult ; Cisplatin/therapeutic use ; Combined Modality Therapy ; Etoposide/therapeutic use ; Humans ; Male ; Neoplasm Recurrence, Local/pathology ; Thymoma/pathology
Czasopismo naukowe
Tytuł :
A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations.
Autorzy :
Piri SM; Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Edalatfar M; Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Shool S; Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Jalalian MN; Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Tavakolpour S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Infectious diseases (London, England) [Infect Dis (Lond)] 2021 May; Vol. 53 (5), pp. 315-324. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Recurrence*
COVID-19/*diagnosis
Antibodies, Viral/blood ; COVID-19 Serological Testing ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Risk Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies